Tyra Biosciences prices $400 million underwritten stock offering
Tyra Biosciences priced a $400 million underwritten offering of common stock and pre-funded warrants.
, Sept. 14, 2026 // -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced the pricing o…